The AI workspace for pharma market research

Get instant access to pharma datasets and AI-powered research to make faster business decisions.

Market Size Estimate Pricing Intelligence Target Account List Market Study

Introducing PharmaDB

Datasets New

Access multiple datasets for a single subscription.

Product registries data Coming soon

Marketing authorization and drug registration data across 100s of countries.

Company/People data Coming soon

Lists of all global pharmaceutical companies and key contacts.

FDA data Coming soon

Comprehensively organised FDA data.

Trade Data

DATE PRODUCT GENERIC QTY UNIT HS CODE
Jul 31, 2025 GLYXAMBI 25M... empaglifl... 8 NOS 30049099
Jul 30, 2025 Glyxambi Tab... empaglifl... 36 NOS 30049099
Jul 26, 2025 GLYXAMBI 10\5... empaglifl... 1 PCS 30049099
Jul 23, 2025 GLYXAMBI 10/5... empaglifl... 48 NOS 30049099
Jul 17, 2025 GLYXAMBI 25M... empaglifl... 2 NOS 30049099

Showing 5 of 616 rows

AI copilot New

Ask, research or brainstorm with your AI copilot.

Treat the copilot as your personal analyst. Ask it anything and it will write SQL queries, pull relevant data from datasets, research the internet, and deliver clear responses with visual insights.

Product variant distribution chart

Nivolumab Product Variant Distribution

Analysis of 84 export transactions across 54 unique product variants

54
Unique Product Variants
84
Total Transactions
7.1%
Top Variant Share
Top 10 Product Variants by Transaction Volume
OPDYTA 40MG
24.0%
Opdivo 40mg Injection
12.0%
NIVOLUMAB 40MG
8.0%
NIVOLUMAB Test
8.0%
Export anything

Easily export any data.

Export to CSV
Download spreadsheet
Export to Excel
Download workbook
Export to PDF
Download report
Share easily

Share your work with your team.

Market Analysis Report
Generated by AI Copilot
Customise your copilot

Give your copilot complete context about your business.

Copilot Settings

Active
Product Portfolio
12 products
Business Context
3 documents
Target Markets
8 regions

See what PharmaDB can do.

Explore all use cases →

Market size estimates and forecasts

Explore →
2023 $8.2B
2024 $10.5B
2025 $13.8B
2026 $18.2B
CAGR +30.2%

Competitor landscape

Explore →
Market Share
Innovation
Your Company
Leader
Established
Emerging

Build target account lists

Explore →
Target Accounts 142 companies
Pfizer Inc.
Tier 1 • US
95
Novartis AG
Tier 1 • EU
88
Roche Holdings
Tier 2 • CH
72
Merck & Co.
Tier 2 • US
61